SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans
As the COVID-19 pandemic continues, the authorization of vaccines for emergency use has been crucial in slowing down the rate of infection and transmission of the SARS-CoV-2 virus that causes COVID-19. In order to investigate the longitudinal serological responses to SARS-CoV-2 natural infection and...
Main Authors: | David Forgacs, Hyesun Jang, Rodrigo B. Abreu, Hannah B. Hanley, Jasper L. Gattiker, Alexandria M. Jefferson, Ted M. Ross |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.728021/full |
Similar Items
-
BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers
by: Federico Pratesi, et al.
Published: (2021-06-01) -
Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults
by: Maria Raffaella Petrara, et al.
Published: (2021-09-01) -
Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals
by: Guo, W., et al.
Published: (2022) -
SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
by: Emily Bettini, et al.
Published: (2021-02-01) -
Viral and Immunological Analytes are Poor Predictors of the Clinical Treatment Response in Kaposi’s Sarcoma Patients
by: Salum J. Lidenge, et al.
Published: (2020-06-01)